Page last updated: 2024-10-26

donepezil and Movement Disorders

donepezil has been researched along with Movement Disorders in 5 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research Excerpts

ExcerptRelevanceReference
"Donepezil was increased to 10 mg, and 2 months later, the patient developed dropped head syndrome."1.91[Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases]. ( Komatsu, K; Takahashi, M; Ueda, A, 2023)
"Donepezil treatment reduced cholesterol accumulation in adult neural stem cells in vitro, and it downregulated the expression of the cholesterol synthesis factors' sterol regulatory element-binding proteins and 3-hydroxy-3-methylglutaryl-CoA reductase in the cerebellum, implying that AChE activity might be associated with cholesterol homeostasis."1.40Donepezil enhances Purkinje cell survival and alleviates motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann Pick disease type C. ( Choi, SW; Hong, IS; Kang, I; Kang, KS; Kim, HS; Seo, Y; Shin, Y; Yu, KR, 2014)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ueda, A1
Komatsu, K1
Takahashi, M1
Seo, Y1
Shin, Y1
Kim, HS1
Kang, I1
Hong, IS1
Choi, SW1
Yu, KR1
Kang, KS1
Thomas Antérion, C1
Convers, P1
Desmales, S1
Borg, C1
Laurent, B1
Leelavathi, M1
Rosdinom, R1
Suguna, M1
Amouyal-Barkate, K1
Bagheri-Charabiani, H1
Montastruc, JL1
Moulias, S1
Vellas, B1

Other Studies

5 other studies available for donepezil and Movement Disorders

ArticleYear
[Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases].
    Rinsho shinkeigaku = Clinical neurology, 2023, Feb-25, Volume: 63, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; In

2023
Donepezil enhances Purkinje cell survival and alleviates motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann Pick disease type C.
    Journal of neuropathology and experimental neurology, 2014, Volume: 73, Issue:3

    Topics: Adult Stem Cells; Animals; ATP-Binding Cassette Transporters; Cell Survival; Cells, Cultured; Cerebe

2014
An odd manifestation of the Capgras syndrome: loss of familiarity even with the sexual partner.
    Neurophysiologie clinique = Clinical neurophysiology, 2008, Volume: 38, Issue:3

    Topics: Aged; Amnesia; Antipsychotic Agents; Atrophy; Brain; Capgras Syndrome; Donepezil; Hallucinations; Hu

2008
Pisa syndrome secondary to rivastigmine: a case report.
    La Clinica terapeutica, 2012, Volume: 163, Issue:1

    Topics: Aged; Benzodiazepines; Cholinesterase Inhibitors; Delusions; Dementia; Donepezil; Humans; Indans; Ma

2012
Abnormal movements with donepezil in Alzheimer disease.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:11

    Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Hum

2000